The Psychological Impact of Prenatal Diagnosis and Disclosure of Susceptibility Loci: First Impressions of Parents' Experiences. Issue 6 (25th May 2016)

• Record Type: Journal Article
• Authors: van der Steen, S. L.; Riedijk, S. R.; Verhagen‐Visser, J.; Govaerts, L. C. P.; Srebniak, M. I.; Van Opstal, D.; Joosten, M.; Knapen, M. F. C. M.; Tibben, A.; Diderich, K. E. M.; Galjaard, R. J. H.
• Is Part Of: Journal of genetic counseling. Volume 25:Issue 6(2016)
• Page Start: 1227
• Page End: 1234
• Publication Date: 2016-05-25
• Subjects: Invasive prenatal diagnosis -- Susceptibility loci -- VOUS -- CNV -- Psychological impact -- Genomic microarray -- Uncertainty -- Individualized choice; Genetic counseling -- Periodicals; 616.042
• DOI: 10.1007/s10897-016-9960-y
• Languages: English
• ISSNs: 1059-7700

Abstract

Abstract: Genomic microarray may detect susceptibility loci (SL) for neurodevelopmental disorders such as autism and epilepsy, with a yet unquantifiable risk for the fetus. The prenatal disclosure of susceptibility loci is a topic of much debate. Many health care professionals fear that reporting susceptibility loci may put a psychological burden on pregnant couples. It is our policy to disclose prenatal susceptibility loci as we recognize them as actionable for prospective parents. The aim of this report was to evaluate the psychological impact of disclosing a prenatal diagnosis of susceptibility loci. The psychological impact of disclosing susceptibility loci was evaluated in the first patients who received such results. Eight out of 15 women who had a susceptibility locus disclosed and four of their partners consented to share their experiences through a telephonic evaluation ( n = 12). Follow‐up time ranged from 3 to 15 months after their prenatal test result. The reporting of susceptibility loci was initially 'shocking' for five parents while the other seven felt 'worried'. Ten out of 12 participants indicated they would like to be informed about the susceptibility locus again, two were unsure. Most had no enduring worries. Participants unanimously indicated that pregnant couples should have an individualized pre‐test choice about susceptibility loci (non)disclosure. We observed no negative psychological impact with the prenatal diagnosis and disclosure of SL on participants. A key factor in mitigating parental anxiety with SL disclosure appears to be post‐test genetic counseling. Our report confirms that pregnant women and their partners prefer an individualized choice regarding the scope of prenatal testing.